These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 11402222)

  • 41. Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis.
    Lewis W; Kohler JJ; Hosseini SH; Haase CP; Copeland WC; Bienstock RJ; Ludaway T; McNaught J; Russ R; Stuart T; Santoianni R
    AIDS; 2006 Mar; 20(5):675-84. PubMed ID: 16514297
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mitochondrial toxicity.
    Scoular A
    J HIV Ther; 2001 Mar; 6(1):1-3. PubMed ID: 11501195
    [No Abstract]   [Full Text] [Related]  

  • 43. Transplacentally exposed human and monkey newborn infants show similar evidence of nucleoside reverse transcriptase inhibitor-induced mitochondrial toxicity.
    Divi RL; Leonard SL; Kuo MM; Nagashima K; Thamire C; St Claire MC; Wade NA; Walker VE; Poirier MC
    Environ Mol Mutagen; 2007; 48(3-4):201-9. PubMed ID: 16538687
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is there a role for nitric oxide in hyperlactataemia syndromes and mitochondrial dysfunction associated with HIV therapy?
    Torre D; Speranza F
    Lancet Infect Dis; 2003 Oct; 3(10):609-10. PubMed ID: 14522259
    [No Abstract]   [Full Text] [Related]  

  • 45. Oxidative stress in NRTI-induced toxicity: evidence from clinical experience and experiments in vitro and in vivo.
    Day BJ; Lewis W
    Cardiovasc Toxicol; 2004; 4(3):207-16. PubMed ID: 15470269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mitochondrial damage by antiretrovirals: diagnosis and monitoring].
    de Mendoza C; Blanco F; Soriano V
    Med Clin (Barc); 2003 Sep; 121(8):310-5. PubMed ID: 14499088
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Brain mitochondrial injury in human immunodeficiency virus-seropositive (HIV+) individuals taking nucleoside reverse transcriptase inhibitors.
    Schweinsburg BC; Taylor MJ; Alhassoon OM; Gonzalez R; Brown GG; Ellis RJ; Letendre S; Videen JS; McCutchan JA; Patterson TL; Grant I;
    J Neurovirol; 2005 Aug; 11(4):356-64. PubMed ID: 16206458
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Mitochondrial cytopathies associated with HIV infection].
    Gérard Y; Melliez H; Mouton Y; Yazdanpanah Y
    Rev Neurol (Paris); 2006 Jan; 162(1):62-70. PubMed ID: 16446624
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria.
    Moyle G
    Antivir Ther; 2005; 10 Suppl 2():M47-52. PubMed ID: 16152705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mitochondrial toxicity and lactic acidosis.
    Proj Inf Perspect; 2000 Mar; (29):10-1. PubMed ID: 12772662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitochondrial interference by anti-HIV drugs: mechanisms beyond Pol-γ inhibition.
    Apostolova N; Blas-García A; Esplugues JV
    Trends Pharmacol Sci; 2011 Dec; 32(12):715-25. PubMed ID: 21899897
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective.
    Lewis W; Day BJ; Copeland WC
    Nat Rev Drug Discov; 2003 Oct; 2(10):812-22. PubMed ID: 14526384
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonclinical Safety Profile of BMS-986001, a Nucleoside Transcriptase Inhibitor for Combination Retroviral Therapy.
    Mausumee G; Frank S; Shawn C; Dara H; Zhao Y; Soleil PM; Sanderson TP; Michael G; Marc D
    Int J Toxicol; 2014 May; 33(3):204-218. PubMed ID: 24846376
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
    Pace CS; Martin AM; Hammond EL; Mamotte CD; Nolan DA; Mallal SA
    Antivir Ther; 2003 Aug; 8(4):323-31. PubMed ID: 14518702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nucleoside reverse transcriptase inhibitors induced hepatocellular mitochondrial DNA lesions and compensatory enhancement of mitochondrial function and DNA repair.
    Liang Q; Zeng J; Wu J; Qiao L; Chen Q; Chen D; Zhang Y
    Int J Antimicrob Agents; 2018 Mar; 51(3):385-392. PubMed ID: 28843815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?
    Maagaard A; Kvale D
    J Antimicrob Chemother; 2009 Nov; 64(5):901-9. PubMed ID: 19740910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
    Lewis W
    Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nucleoside analogues and neuropathy in the era of HAART.
    Cherry CL; McArthur JC; Hoy JF; Wesselingh SL
    J Clin Virol; 2003 Feb; 26(2):195-207. PubMed ID: 12600651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mitochondrial toxicity in HAART: an overview of in vitro evidence.
    Apostolova N; Blas-García A; Esplugues JV
    Curr Pharm Des; 2011; 17(20):2130-44. PubMed ID: 21718249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transgenic expression of the deoxynucleotide carrier causes mitochondrial damage that is enhanced by NRTIs for AIDS.
    Lewis W; Haase CP; Miller YK; Ferguson B; Stuart T; Ludaway T; McNaught J; Russ R; Steltzer J; Santoianni R; Long R; Fiermonte G; Palmieri F
    Lab Invest; 2005 Aug; 85(8):972-81. PubMed ID: 15951836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.